Markets around the world were rattled after Moderna’s CEO cast doubt on the efficacy of COVID-19 vaccines against the Omicron variant. But John Stoltzfus of Oppenheimer Asset Management says pharmaceutical companies are well positioned to adapt pic.twitter.com/Y38t6C4Hsq— Reuters (@Reuters) November 30, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


